Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shanghai - Delayed Quote CNY

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS)

Compare
26.33
+1.06
+(4.19%)
At close: April 3 at 3:00:02 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,728,023.67
3,728,023.67
3,136,746.41
3,532,379.04
3,385,059.26
Cost of Revenue
1,992,486.63
1,992,486.63
1,822,074.22
2,034,199.79
2,017,572.11
Gross Profit
1,735,537.04
1,735,537.04
1,314,672.19
1,498,179.25
1,367,487.15
Operating Expense
1,116,528.59
1,116,528.59
898,486.12
971,438.03
893,264.64
Operating Income
619,008.45
619,008.45
416,186.07
526,741.22
474,222.51
Net Non Operating Interest Income Expense
57,598.86
57,598.86
44,320.95
46,278.19
35,836.69
Pretax Income
657,553.69
657,553.69
524,703.24
559,135.16
548,159.11
Tax Provision
109,255.20
109,255.20
72,864
79,784.04
74,108.78
Net Income Common Stockholders
528,093.86
528,093.86
443,250.94
478,571.95
464,591.71
Basic EPS
1.23
--
1.03
1.11
1.08
Diluted EPS
1.23
--
1.03
1.11
1.08
Basic Average Shares
429,344.60
--
430,340.71
431,145.90
430,177.51
Diluted Average Shares
429,344.60
--
430,340.71
431,145.90
430,177.51
Total Operating Income as Reported
666,822.02
666,822.02
536,628.34
555,538.27
550,305.15
Rent Expense Supplemental
5,671.27
5,671.27
5,615.01
5,408.60
7,196.67
Total Expenses
3,109,015.22
3,109,015.22
2,720,560.33
3,005,637.82
2,910,836.75
Net Income from Continuing & Discontinued Operation
528,093.86
528,093.86
443,250.94
478,571.95
464,591.71
Normalized Income
547,598.14
547,598.14
455,696.29
528,193.95
457,490.02
Interest Income
65,218.02
65,218.02
60,980.29
58,562.81
46,603.94
Interest Expense
7,376.55
7,376.55
16,854.17
11,687.93
10,207.80
Net Interest Income
57,598.86
57,598.86
44,320.95
46,278.19
35,836.69
EBIT
664,930.25
664,930.25
541,557.40
570,823.09
558,366.92
EBITDA
745,931.39
745,931.39
622,120.72
649,333.17
626,933.25
Reconciled Cost of Revenue
1,992,486.63
1,992,486.63
1,822,074.22
2,034,199.79
2,017,572.11
Reconciled Depreciation
81,001.14
81,001.14
80,563.31
78,510.08
68,566.34
Net Income from Continuing Operation Net Minority Interest
528,093.86
528,093.86
443,250.94
478,571.95
464,591.71
Total Unusual Items Excluding Goodwill
-23,390.75
-23,390.75
-14,452.31
-57,881.17
8,211.91
Total Unusual Items
-23,390.75
-23,390.75
-14,452.31
-57,881.17
8,211.91
Normalized EBITDA
769,322.13
769,322.13
636,573.02
707,214.34
618,721.34
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,886.47
-3,886.47
-2,006.95
-8,259.17
1,110.22
12/31/2021 - 5/17/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade